Cargando…

How long do new medicines take to reach Canadian patients after companies file a submission: A cohort study

INTRODUCTION: Studies of the delay between when companies file a New Drug Submission (NDS) and when drugs reach Canadian patients typically focus on the time in the regulatory review process and do not analyze the time between when approval is granted and the drug is available for purchase (company...

Descripción completa

Detalles Bibliográficos
Autor principal: Lexchin, Joel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605702/
https://www.ncbi.nlm.nih.gov/pubmed/33137156
http://dx.doi.org/10.1371/journal.pone.0240966